AI Science Tracker
EN

The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach.

Affiliation not stated in the reviewed material · 28 Aug 2023 · medicine

Discovery

The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Publisher full text read in Chrome, Methods and Results: transcriptomic ML analysis of colorectal-cancer samples nominated ASPHD1/ZBTB12 prognostic markers; follow-up qPCR in 64 samples and whole-exome validation in 15 samples. Specific gene-marker associations with experimental validation, but small validation subsets and observational evidence do not establish clinical utility.

Technology: Transcriptomic machine-learning analysis ranked colorectal-cancer prognostic markers, which were checked with qPCR and whole-exome data.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Transcriptomic machine-learning analysis ranked colorectal-cancer prognostic markers, which were checked with qPCR and whole-exome data.
Limitation / still unknown
Publisher full text read in Chrome, Methods and Results: transcriptomic ML analysis of colorectal-cancer samples nominated ASPHD1/ZBTB12 prognostic markers; follow-up qPCR in 64 samples and whole-exome validation in 15 samples. Specific gene-marker associations with experimental validation, but small validation subsets and observational evidence do not establish clinical utility.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.mdpi.com/2072-6694/15/17/4300

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.